By modulating dopamine signaling and reducing what many patients describe as food noise, GLP-1 medications may ease some of the neurological drivers of binge eating, not just the physical experience of hunger
Liraglutide, available under the brand names Saxenda for weight loss and Victoza for type 2 diabetes treatment, has been shown to promote weight loss by reducing appetite, slowing gastric emptying, and increasing energy expenditure
In fact, there was a 2022 case report presented a 22-year-old student who exhibited hyperpigmentation as the only symptom of B12 deficiency
When patients take a semaglutide drug, they feel fuller and their digestion slows down
This adds another layer to the peptides potential applications, extending its relevance from weight management to broader metabolic health
Weight loss also plays a major role